Close Menu
October 21, 2020
Sponsored by

Target Enrichment NGS Panel Outperforms the Gold Standard for Sequence and CNV Analysis


Head of Division of Molecular Diagnostics,
London Health Sciences Centre (LHSC)

Target enrichment has been a major driver behind the clinical adoption of next-generation sequencing (NGS) over the last decade because it simplifies analysis and provides a cost-effective method of massive parallel resequencing. It has not only replaced Sanger sequencing, but it is actively dispensing the need for parallel copy number variant (CNV) analysis using classic techniques.

In this webinar, Bekim Sadikovic of the London Health Sciences Centre will demonstrate the performance of Roche’s new KAPA Target Enrichment technology in custom gene panels.

Dr. Sadikovic’s team has streamlined a clinically validated and robust CNV detection algorithm using targeted NGS gene panel data from the Roche SeqCap EZ platform, which they have used to assess complex genomic regions, including pseudogenic DNA sequences and mitochondrial genome heteroplasmy.

In this webinar, Dr. Sadikovic will share details of his team’s evaluation of the new KAPA technology in custom gene panels, including hereditary oncology, mitochondrial disorders, and Charcot-Marie Tooth disease, by using samples previously tested in his lab.

For Research Use Only. Not for use in diagnostic purposes.

KAPA, HYPEREXOME, and SEQCAP are trademarks of Roche. All other product names and trademarks are the property of their respective owner.

Sponsored by

Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.

The New York Times reports that developers in New York City are increasingly interested in life science spaces.

A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.

Sponsored by

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Sponsored by

Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.

Sponsored by

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Sponsored by
Akoya Biosciences

Most recent single-cell and spatial biology studies have focused on the network of interactions between different cell types and their spatial context.